Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial

Coleman RL;Oza AM;Lorusso D;Aghajanian C;Oaknin A;Dean A;Colombo N;Weberpals JI;Clamp A;Scambia G;Leary A;Holloway RW;Gancedo MA;Fong PC;Goh JC;O'Malley DM;Armstrong DK;Garcia-Donas J;Swisher EM;Floquet A;Konecny GE;McNeish IA;Scott CL;Cameron T;Maloney L;Isaacson J;Goble S;Grace C;Harding TC;Raponi M;Sun J;Lin KK;Giordano H;Ledermann JA;ARIEL3 investigators.

2017-01-01